We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > claims

News List

FDA Warns CBD Product Maker About False Claims drugs
July 25, 2019
A warning letter has been issued to Massachusetts-based Curaleaf Inc. for illegally selling unapproved cannabidiol (CBD) products online with unproven claims ...
EpiPen partners Mylan, Pfizer have to fight class action over 'egregious' antitrust claims fiercepharma
August 23, 2018
Mylan's EpiPen was at the center of a price hike scandal that started in 2016. (Greg Friese/Flickr)
With its case count climbing, Johnson & Johnson faces major test in talc defense fiercepharma
June 07, 2018
After experiencing mixed results in defense of its storied Johnson's Baby Powder brand, Johnson & Johnson faces its biggest legal test yet for the product.